CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 245 enrolled
Drug / intervention
Trifecta valvedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01514162
NCT01514162N/ACompleted

Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve

Abbott Medical Devices·interventional·Posted Jan 20, 2012·Updated Feb 15, 2019

In Brief

A clinical study evaluating Trifecta valve for Heart Valve Diseases. Completed, enrolled 245 participants across 6 sites.

Detailed Summary

To further evaluate the long term clinical safety and effectiveness of the Trifecta valve

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 20, 2012
Enrollment StartFeb 1, 2012
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 14.5 years ago

Interventions

Trifecta valvedevice

surgical replacement of aortic valve